This is a Validated Antibody Database (VAD) review about dog TJP2, based on 45 published articles (read how Labome selects the articles), using TJP2 antibody in all methods. It is aimed to help Labome visitors find the most suited TJP2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TJP2 synonym: ZO-2; tight junction protein ZO-2; zona occludens 2; zona occludens protein 2; zonula occludens protein 2

Knockout validation
Invitrogen
rabbit polyclonal
  • western blot knockout validation; rat; loading ...; fig 4d
In order to visualize the interaction of claudin, ZO-1 and actin in epithelial tight juntions., Invitrogen TJP2 antibody (GE Healthcare, 38-9100) was used in western blot knockout validation on rat samples (fig 4d). Mol Biol Cell (2017) ncbi
Invitrogen
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3s2a
Invitrogen TJP2 antibody (ThermoFisher, 711400) was used in western blot on human samples at 1:1000 (fig 3s2a). elife (2019) ncbi
rabbit polyclonal
  • proximity ligation assay; dog; 1:100
  • immunocytochemistry; dog; 1:100; loading ...; fig 1a
  • western blot; dog; 1:1000; loading ...; fig 1a
In order to investigate that role of zonula occludens-2 in Rho protein activation and epithelial development, Invitrogen TJP2 antibody (Invitrogen, 711400) was used in proximity ligation assay on dog samples at 1:100, in immunocytochemistry on dog samples at 1:100 (fig 1a) and in western blot on dog samples at 1:1000 (fig 1a). Biochim Biophys Acta Mol Cell Res (2017) ncbi
rabbit polyclonal
  • western blot knockout validation; rat; loading ...; fig 4d
In order to visualize the interaction of claudin, ZO-1 and actin in epithelial tight juntions., Invitrogen TJP2 antibody (GE Healthcare, 38-9100) was used in western blot knockout validation on rat samples (fig 4d). Mol Biol Cell (2017) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; fig 1A
In order to assess induction of renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway due to ZO-2 silencing, Invitrogen TJP2 antibody (Invitrogen, 711400) was used in immunocytochemistry on dog samples (fig 1A). Mol Biol Cell (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:50; fig 2b
  • western blot; human; 1:1000; fig 2a
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunocytochemistry on human samples at 1:50 (fig 2b) and in western blot on human samples at 1:1000 (fig 2a). Exp Cell Res (2015) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200
In order to describe a miRNA-dependent mechanism of Dicer in reestablishing the barrier function of the skin post-wounding, Invitrogen TJP2 antibody (Invitrogen, 38-9,100) was used in immunohistochemistry - frozen section on mouse samples at 1:200. Mol Ther (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; dog
In order to characterize TALEN-mediated claudin-2 knockout in MDCK cells, Invitrogen TJP2 antibody (Invitrogen, 38-9100) was used in immunocytochemistry on dog samples . PLoS ONE (2015) ncbi
rabbit polyclonal
  • western blot; human
In order to investigate the effect of homoharringtonine on intestinal epithelial permeability and its mechanism, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in western blot on human samples . Eur J Pharm Biopharm (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:500; fig 3
  • western blot; mouse; 1:500; fig 6
  • immunohistochemistry - paraffin section; rat; 1:500; fig 7
In order to study the contribution of ZO-1, -2, and -3 on collecting duct cell proliferation, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunocytochemistry on mouse samples at 1:500 (fig 3), in western blot on mouse samples at 1:500 (fig 6) and in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 7). Cell Cycle (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:400
In order to study the role of down syndrome cell adhesion molecule during mice retina development, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunohistochemistry on mouse samples at 1:400. Mol Vis (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; dog
  • western blot; dog
In order to characterize the TALEN-mediated ZO-1 knockout in MDCK cells, Invitrogen TJP2 antibody (Invitrogen, 38-9100) was used in immunocytochemistry on dog samples and in western blot on dog samples . PLoS ONE (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:100; fig s5
In order to analyze the barrier properties of mouse brain endothelial cells and stabilizing adherens junctions due to heparan sulfate proteoglycan agrin, Invitrogen TJP2 antibody (Zymed, 71-1400) was used in immunocytochemistry on mouse samples at 1:100 (fig s5). Cell Tissue Res (2014) ncbi
rabbit polyclonal
  • western blot; dog
In order to study the role of ZO proteins in the regulation of transcription factor DbpA/ZONAB, Invitrogen TJP2 antibody (Zymed, 71-1400) was used in western blot on dog samples . J Biol Chem (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; fig 2
  • western blot; mouse; 1:1000; fig 1
In order to investigate the expression of the tight junction proteins occludin, claudin-1 and ZO-2 in the epidermis of female mice, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2) and in western blot on mouse samples at 1:1000 (fig 1). Exp Cell Res (2013) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000
In order to study the effect of endotoxemia on the progression of encephalopathy in relation to BBB permeability during acute liver failure, Invitrogen TJP2 antibody (Invitrogen, 38-9100) was used in western blot on mouse samples at 1:1000. Liver Int (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
In order to investigate the regulation of ZO-1 by p38delta mitogen-activated protein kinase in differentiating human epidermal keratinocytes, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in western blot on human samples at 1:1000. Arch Dermatol Res (2014) ncbi
mouse monoclonal (3E8D9)
  • western blot; human; 1:1000
In order to investigate the regulation of ZO-1 by p38delta mitogen-activated protein kinase in differentiating human epidermal keratinocytes, Invitrogen TJP2 antibody (Invitrogen, 37-4700) was used in western blot on human samples at 1:1000. Arch Dermatol Res (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; 1:100
In order to identify the mechanism for the vascular permeability syndrome and respiratory distress in severe dengue, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunocytochemistry on dog samples at 1:100. J Virol (2013) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; fig 7
In order to use Isl1-Cre to investigate the roles of Foxa2 in the prechordal plate and ventral endoderm, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunohistochemistry on mouse samples at 1:200 (fig 7). Biol Open (2012) ncbi
rabbit polyclonal
  • immunohistochemistry - free floating section; mouse; 1:50; fig 3
In order to assess the relationship between zona occludens-2 and the Wnt/beta-catenin pathway in podocyte injury and proteinuria, Invitrogen TJP2 antibody (Zymed, 71-1400) was used in immunohistochemistry - free floating section on mouse samples at 1:50 (fig 3). Am J Physiol Renal Physiol (2013) ncbi
mouse monoclonal (3E8D9)
  • immunocytochemistry; human; 1:250; fig 7
  • western blot; human; 1:1000; fig 7
In order to study permeability and tight junctions in endothelial cells derived from human cord blood, Invitrogen TJP2 antibody (Invitrogen, 3E8D9) was used in immunocytochemistry on human samples at 1:250 (fig 7) and in western blot on human samples at 1:1000 (fig 7). Am J Physiol Heart Circ Physiol (2012) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:30; fig 2
In order to determine the expression pattern of selected components involved in the formation of tight junctions in relation to gastroesophageal reflux disease, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunohistochemistry on human samples at 1:30 (fig 2). BMC Gastroenterol (2012) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; fig 2
In order to investigate the roles of ZO-1 in mouse embryonic stem cells, Invitrogen TJP2 antibody (Zymed, 71-1400) was used in immunocytochemistry on mouse samples (fig 2). Stem Cells (2012) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; fig 5
In order to study the junctional complexes of liver sinusoidal endothelial cells, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunohistochemistry on rat samples (fig 5). PLoS ONE (2012) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; loading ...; fig 2e
In order to investigate the effect of ouabain on cilia development in epithelial cells, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunocytochemistry on dog samples (fig 2e). Proc Natl Acad Sci U S A (2011) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; tbl 1
In order to assess the effects of stabilizing the blood brain barrier function by therapeutic targeting tight junction proteins for experimental autoimmune encephalomyelitis, Invitrogen TJP2 antibody (Zymed, 71-1400) was used in immunohistochemistry - frozen section on mouse samples (tbl 1). Acta Neuropathol (2011) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; fig 1
In order to elucidate the role of zonula occludens-2 in trophectoderm differentiation and blastocyst formation in hamsters, Invitrogen TJP2 antibody (Invitrogen, 71-1400) was used in immunocytochemistry on mouse samples (fig 1). Theriogenology (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; fig 4
In order to discuss the mechanisms by which the blood brain barrier and the blood-cerebrospinal fluid barrier are dysregulated during inflammation, Invitrogen TJP2 antibody (Zymed, 71-1400) was used in immunohistochemistry on mouse samples (fig 4). Antioxid Redox Signal (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; fig s2
  • western blot; mouse; fig s2
In order to study the role of CD44 in tight-junction assembly and barrier function, Invitrogen TJP2 antibody (Zymed, 38-9100) was used in immunohistochemistry on mouse samples (fig s2) and in western blot on mouse samples (fig s2). J Invest Dermatol (2011) ncbi
rabbit polyclonal
  • immunoprecipitation; dog; fig 3
  • immunocytochemistry; dog; 1:100; fig 4
  • western blot; dog; 1:1000; fig 3
In order to identify ZASP as a binding partner of ZO-2, Invitrogen TJP2 antibody (Zymed, 71-1400) was used in immunoprecipitation on dog samples (fig 3), in immunocytochemistry on dog samples at 1:100 (fig 4) and in western blot on dog samples at 1:1000 (fig 3). Exp Cell Res (2010) ncbi
rabbit polyclonal
  • western blot; sheep; 1:5000
In order to measure the expression of tight junction proteins in the cerebral cortex, cerebellum, and spinal cord of fetuses after maternal treatment with dexamethasone, Invitrogen TJP2 antibody (Zymed, 71-1400) was used in western blot on sheep samples at 1:5000. Am J Physiol Heart Circ Physiol (2010) ncbi
rabbit polyclonal
In order to examine the architecture of cellular junctions present in blood and lymphatic vessel endothelium in peripheral lymph nodes, Invitrogen TJP2 antibody (Zymed, 71-1400) was used . Eur J Immunol (2008) ncbi
mouse monoclonal (3E8D9)
  • flow cytometry; human; fig 4
In order to describe a cancer stem cell gene-expression signature, Invitrogen TJP2 antibody (Zymed Laboratories, 3E8D9) was used in flow cytometry on human samples (fig 4). Genome Biol (2008) ncbi
rabbit polyclonal
In order to study the effects of cingulin overexpression, Invitrogen TJP2 antibody (Zymed, 71- 1400) was used . Mol Membr Biol (2008) ncbi
mouse monoclonal (3E8D9)
  • immunoprecipitation; dog
In order to investigate the role of zona occludens-2 in the regulation of cyclin D1 transcription, Invitrogen TJP2 antibody (Zymed Laboratories, 37-4700) was used in immunoprecipitation on dog samples . Mol Biol Cell (2007) ncbi
rabbit polyclonal
In order to investigate the role of zona occludens-2 in the regulation of cyclin D1 transcription, Invitrogen TJP2 antibody (Zymed Laboratories, 71-1400) was used . Mol Biol Cell (2007) ncbi
rabbit polyclonal
In order to ascertain the role of ZO-2 in epithelial cells, Invitrogen TJP2 antibody (Zymed Laboratories, 71-1400) was used . Exp Cell Res (2007) ncbi
rabbit polyclonal
In order to study the co-association of connexin36, zonula occludens-1, zonula occludens-2, and Y-box transcription factor 3 in mouse and rat retina, Invitrogen TJP2 antibody (Invitrogen/Zymed, 71-1400) was used . Neuroscience (2006) ncbi
rabbit polyclonal
In order to test if HDAC inhibitors affect the expression of tight junction proteins, Invitrogen TJP2 antibody (Zymed, 71-1400) was used . Mol Cancer Res (2004) ncbi
rabbit polyclonal
In order to test if lack of junctional cingulin affects tight-junction organization and function, Invitrogen TJP2 antibody (Zymed, 71-1400) was used . J Cell Sci (2004) ncbi
rabbit polyclonal
In order to characterize the nuclear functions of ZO-2, Invitrogen TJP2 antibody (Zymed, 71-1400) was used . Exp Cell Res (2004) ncbi
rabbit polyclonal
In order to characterize the disruption of the barrier integrity in rat ileum after irradiation, Invitrogen TJP2 antibody (Zymed, 71-1400) was used . Can J Physiol Pharmacol (2004) ncbi
rabbit polyclonal
In order to examine the role of nuclear ZO-2, Invitrogen TJP2 antibody (Zymed, 71-1400) was used . Exp Cell Res (2004) ncbi
rabbit polyclonal
In order to investigate the use of vitamin D analogues to treat colon cancer, Invitrogen TJP2 antibody (Zymed, 71-1400) was used . J Cell Biol (2001) ncbi
Cell Signaling Technology
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s8
Cell Signaling Technology TJP2 antibody (Cell Signaling Technology, 2847) was used in western blot on human samples at 1:1000 (fig s8). J Clin Invest (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; fig 5b
  • western blot; mouse; 1:1000; fig 5f
Cell Signaling Technology TJP2 antibody (Cell Signaling Technology, 2847) was used in immunohistochemistry on mouse samples at 1:100 (fig 5b) and in western blot on mouse samples at 1:1000 (fig 5f). Endocrinology (2015) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; fig 7
In order to determine the precise role of actin in the neural epithelium, Cell Signaling Technology TJP2 antibody (Cell Signaling, 2847) was used in immunohistochemistry on mouse samples at 1:200 (fig 7). Development (2015) ncbi
Articles Reviewed
  1. Fearnley G, Young K, Edgar J, Antrobus R, Hay I, Liang W, et al. The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion. elife. 2019;8: pubmed publisher
  2. Raya Sandino A, Castillo Kauil A, Domínguez Calderón A, Alarcón L, Flores Benitez D, Cuellar Perez F, et al. Zonula occludens-2 regulates Rho proteins activity and the development of epithelial cytoarchitecture and barrier function. Biochim Biophys Acta Mol Cell Res. 2017;1864:1714-1733 pubmed publisher
  3. Van Itallie C, Tietgens A, Anderson J. Visualizing the dynamic coupling of claudin strands to the actin cytoskeleton through ZO-1. Mol Biol Cell. 2017;28:524-534 pubmed publisher
  4. Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed publisher
  5. Domínguez Calderón A, Ávila Flores A, Ponce A, López Bayghen E, Calderón Salinas J, Luis Reyes J, et al. ZO-2 silencing induces renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway. Mol Biol Cell. 2016;27:1581-95 pubmed publisher
  6. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  7. Dong H, Chen Z, Wang C, Xiong Z, Zhao W, Jia C, et al. Rictor Regulates Spermatogenesis by Controlling Sertoli Cell Cytoskeletal Organization and Cell Polarity in the Mouse Testis. Endocrinology. 2015;156:4244-56 pubmed publisher
  8. Ghatak S, Chan Y, Khanna S, Banerjee J, Weist J, Roy S, et al. Barrier Function of the Repaired Skin Is Disrupted Following Arrest of Dicer in Keratinocytes. Mol Ther. 2015;23:1201-1210 pubmed publisher
  9. Tokuda S, Furuse M. Claudin-2 knockout by TALEN-mediated gene targeting in MDCK cells: claudin-2 independently determines the leaky property of tight junctions in MDCK cells. PLoS ONE. 2015;10:e0119869 pubmed publisher
  10. Grego Bessa J, Hildebrand J, Anderson K. Morphogenesis of the mouse neural plate depends on distinct roles of cofilin 1 in apical and basal epithelial domains. Development. 2015;142:1305-14 pubmed publisher
  11. Watari A, Hashegawa M, Yagi K, Kondoh M. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers. Eur J Pharm Biopharm. 2015;89:232-8 pubmed publisher
  12. Qiao X, Roth I, Féraille E, Hasler U. Different effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion. Cell Cycle. 2014;13:3059-75 pubmed publisher
  13. de Andrade G, Kunzelman L, Merrill M, Fuerst P. Developmentally dynamic colocalization patterns of DSCAM with adhesion and synaptic proteins in the mouse retina. Mol Vis. 2014;20:1422-33 pubmed
  14. Tokuda S, Higashi T, Furuse M. ZO-1 knockout by TALEN-mediated gene targeting in MDCK cells: involvement of ZO-1 in the regulation of cytoskeleton and cell shape. PLoS ONE. 2014;9:e104994 pubmed publisher
  15. Steiner E, Enzmann G, Lyck R, Lin S, Ruegg M, Kroger S, et al. The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions. Cell Tissue Res. 2014;358:465-79 pubmed publisher
  16. Spadaro D, Tapia R, Jond L, Sudol M, Fanning A, Citi S. ZO proteins redundantly regulate the transcription factor DbpA/ZONAB. J Biol Chem. 2014;289:22500-11 pubmed publisher
  17. Hernández Monge J, Garay E, Raya Sandino A, Vargas Sierra O, Diaz Chavez J, Popoca Cuaya M, et al. Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis. Exp Cell Res. 2013;319:2588-603 pubmed publisher
  18. Chastre A, Belanger M, Nguyen B, Butterworth R. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. Liver Int. 2014;34:353-61 pubmed publisher
  19. Siljamäki E, Raiko L, Toriseva M, Nissinen L, Näreoja T, Peltonen J, et al. p38? mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes. Arch Dermatol Res. 2014;306:131-41 pubmed publisher
  20. Puerta Guardo H, Raya Sandino A, Gonzalez Mariscal L, Rosales V, Ayala Davila J, Chávez Mungía B, et al. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. J Virol. 2013;87:7486-501 pubmed publisher
  21. Harrelson Z, Kaestner K, Evans S. Foxa2 mediates critical functions of prechordal plate in patterning and morphogenesis and is cell autonomously required for early ventral endoderm morphogenesis. Biol Open. 2012;1:173-81 pubmed publisher
  22. Bautista García P, Reyes J, Martin D, Namorado M, Chavez Munguia B, Soria Castro E, et al. Zona occludens-2 protects against podocyte dysfunction induced by ADR in mice. Am J Physiol Renal Physiol. 2013;304:F77-87 pubmed publisher
  23. Cheung T, Ganatra M, Peters E, Truskey G. Effect of cellular senescence on the albumin permeability of blood-derived endothelial cells. Am J Physiol Heart Circ Physiol. 2012;303:H1374-83 pubmed publisher
  24. Monkemuller K, Wex T, Kuester D, Fry L, Kandulski A, Kropf S, et al. Role of tight junction proteins in gastroesophageal reflux disease. BMC Gastroenterol. 2012;12:128 pubmed publisher
  25. Xu J, Lim S, Ng M, Ali S, Kausalya J, Limviphuvadh V, et al. ZO-1 regulates Erk, Smad1/5/8, Smad2, and RhoA activities to modulate self-renewal and differentiation of mouse embryonic stem cells. Stem Cells. 2012;30:1885-900 pubmed publisher
  26. Géraud C, Evdokimov K, Straub B, Peitsch W, Demory A, Dörflinger Y, et al. Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids. PLoS ONE. 2012;7:e34206 pubmed publisher
  27. Larre I, Castillo A, Flores Maldonado C, Contreras R, Galván I, Muñoz Estrada J, et al. Ouabain modulates ciliogenesis in epithelial cells. Proc Natl Acad Sci U S A. 2011;108:20591-6 pubmed publisher
  28. Pfeiffer F, Schäfer J, Lyck R, Makrides V, Brunner S, Schaeren Wiemers N, et al. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathol. 2011;122:601-14 pubmed publisher
  29. Wang H, Luan L, Ding T, Brown N, Reese J, Paria B. Dynamics of zonula occludens-2 expression during preimplantation embryonic development in the hamster. Theriogenology. 2011;76:678-86 pubmed publisher
  30. Coisne C, Engelhardt B. Tight junctions in brain barriers during central nervous system inflammation. Antioxid Redox Signal. 2011;15:1285-303 pubmed publisher
  31. Kirschner N, Haftek M, Niessen C, Behne M, Furuse M, Moll I, et al. CD44 regulates tight-junction assembly and barrier function. J Invest Dermatol. 2011;131:932-43 pubmed publisher
  32. Lechuga S, Alarcón L, Solano J, Huerta M, Lopez Bayghen E, Gonzalez Mariscal L. Identification of ZASP, a novel protein associated to Zona occludens-2. Exp Cell Res. 2010;316:3124-39 pubmed publisher
  33. Sadowska G, Malaeb S, Stonestreet B. Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep. Am J Physiol Heart Circ Physiol. 2010;298:H179-88 pubmed publisher
  34. Pfeiffer F, Kumar V, Butz S, Vestweber D, Imhof B, Stein J, et al. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur J Immunol. 2008;38:2142-55 pubmed publisher
  35. Birnie R, Bryce S, Roome C, Dussupt V, Droop A, Lang S, et al. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol. 2008;9:R83 pubmed publisher
  36. Paschoud S, Citi S. Inducible overexpression of cingulin in stably transfected MDCK cells does not affect tight junction organization and gene expression. Mol Membr Biol. 2008;25:1-13 pubmed
  37. Huerta M, Munoz R, Tapia R, Soto Reyes E, Ramírez L, Recillas Targa F, et al. Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc. Mol Biol Cell. 2007;18:4826-36 pubmed
  38. Hernandez S, Chavez Munguia B, Gonzalez Mariscal L. ZO-2 silencing in epithelial cells perturbs the gate and fence function of tight junctions and leads to an atypical monolayer architecture. Exp Cell Res. 2007;313:1533-47 pubmed
  39. Ciolofan C, Li X, Olson C, Kamasawa N, Gebhardt B, Yasumura T, et al. Association of connexin36 and zonula occludens-1 with zonula occludens-2 and the transcription factor zonula occludens-1-associated nucleic acid-binding protein at neuronal gap junctions in rodent retina. Neuroscience. 2006;140:433-51 pubmed
  40. Bordin M, D Atri F, Guillemot L, Citi S. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res. 2004;2:692-701 pubmed
  41. Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, et al. Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci. 2004;117:5245-56 pubmed
  42. Jaramillo B, Ponce A, Moreno J, Betanzos A, Huerta M, Lopez Bayghen E, et al. Characterization of the tight junction protein ZO-2 localized at the nucleus of epithelial cells. Exp Cell Res. 2004;297:247-58 pubmed
  43. Dublineau I, Lebrun F, Grison S, Griffiths N. Functional and structural alterations of epithelial barrier properties of rat ileum following X-irradiation. Can J Physiol Pharmacol. 2004;82:84-93 pubmed
  44. Betanzos A, Huerta M, Lopez Bayghen E, Azuara E, Amerena J, Gonzalez Mariscal L. The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res. 2004;292:51-66 pubmed
  45. Pálmer H, González Sancho J, Espada J, Berciano M, Puig I, Baulida J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001;154:369-87 pubmed